Finance

Beta
Lists
OCUL:NASDAQ
Ocular Therapeutix Inc
9,85 US$
-2,62%
(-0,26) 1D
9,76 US$
-0,91% (-0,090)
Pre-market
Closed: 24 ივნ, 16:00:02 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCUL...
Open
10,17 US$
High
10,39 US$
Low
9,74 US$
Mkt. cap
2,16 მლრდ.
Avg. vol.
2,97 მლნ.
Volume
1,01 ათ.
52-wk high
16,44 US$
52-wk low
6,23 US$
EPS
-1,46 US$
Beta
0,89
Shares outstanding
218,96 მლნ.
No. of employees
325
Open
10,17 US$
High
10,39 US$
Low
9,74 US$
Mkt. cap
2,16 მლრდ.
Avg. vol.
2,97 მლნ.
Volume
1,01 ათ.
52-wk high
16,44 US$
52-wk low
6,23 US$
EPS
-1,46 US$
Beta
0,89
Shares outstanding
218,96 მლნ.
No. of employees
325
News stories
From sources across the web
About Ocular Therapeutix Inc
CEOPravin Dugel
Employees325
Founded2006
HeadquartersBedford, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Websiteocutx.com
Analyst Ratings
Based on 9 analysts giving stock ratings to OCUL in the past 3 months
Strong Buy
Buy
9
Hold
0
Sell
0
12 month forecast
Based on 9 Wall Street analysts offering 12 month price targets for OCUL in the last 3 months.
Highest
Current 9,85 US$
31,00 US$ (+214,72%)
Average
25,25 US$ (+156,35%)
Lowest
18,00 US$ (+82,74%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Daniil Gataulin
Chardan Capital
Buy
Maintained
23,00 US$
+133,5%
06/25/2026
Tazeen Ahmad
Bank of America Securities
Buy
Reiterated
27,00 US$
+174,1%
06/22/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
25,00 US$
+153,8%
06/22/2026
Serge Belanger
Needham
Buy
Maintained
18,00 US$
+82,7%
06/18/2026
Biren Amin
Piper Sandler
Buy
Maintained
31,00 US$
+214,7%
06/18/2026
Colleen M. Kusy
Robert W. Baird
Buy
Maintained
30,00 US$
+204,6%
06/18/2026
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
06/18/2026
Lisa Walter
RBC Capital
Buy
Maintained
30,00 US$
+204,6%
05/05/2026
Tara Bancroft
TD Cowen
Buy
Maintained
20,00 US$
+103%
05/05/2026
William Maughan
Clear Street
Buy
Maintained
28,00 US$
+184,3%
03/02/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
-
-
02/17/2026
Clara Dong
Jefferies
Buy
Maintained
28,00 US$
+184,3%
02/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ივნ. 2025
სექ. 2025
დეკ. 2025
მარ. 2026
Revenue
13,46 მლნ.
14,54 მლნ.
13,25 მლნ.
10,78 მლნ.
Cost of goods sold
53,02 მლნ.
54,13 მლნ.
52,39 მლნ.
67,54 მლნ.
Cost of revenue
53,02 მლნ.
54,13 მლნ.
52,39 მლნ.
67,54 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
28,08 მლნ.
29,11 მლნ.
30,62 მლნ.
36,58 მლნ.
Operating expense
28,08 მლნ.
29,11 მლნ.
30,62 მლნ.
36,58 მლნ.
Total operating expenses
81,10 მლნ.
83,24 მლნ.
83,01 მლნ.
104,12 მლნ.
Operating income
-67,64 მლნ.
-68,70 მლნ.
-69,76 მლნ.
-93,34 მლნ.
Other non operating income
-641,00 ათ.
-1,45 მლნ.
624,00 ათ.
1,46 მლნ.
EBT including unusual items
-67,81 მლნ.
-69,42 მლნ.
-64,65 მლნ.
-88,61 მლნ.
EBT excluding unusual items
-67,84 მლნ.
-69,42 მლნ.
-64,62 მლნ.
-88,61 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-67,81 მლნ.
-69,42 მლნ.
-64,65 მლნ.
-88,61 მლნ.
Net profit margin
-503,86%
-477,30%
-487,95%
-821,62%
Earnings per share
-0,39
-0,38
-0,29
-0,40
Interest and investment income
3,46 მლნ.
3,73 მლნ.
7,34 მლნ.
6,05 მლნ.
Interest expense
-3,02 მლნ.
-3,00 მლნ.
-2,83 მლნ.
-2,78 მლნ.
Net interest expenses
439,00 ათ.
727,00 ათ.
4,51 მლნ.
3,27 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-66,62 მლნ.
-67,63 მლნ.
-68,51 მლნ.
-92,06 მლნ.
Gain or loss from assets sale
-29,00 ათ.
-
-
4,87 მლნ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer